A practical dexamethasone suppression test to evaluate hirsute women.
Fifty five hirsute women were subjected to a 2-week dexamethasone (DXM) suppression test. The pre-and post-DXM plasma dehydro-epiandrosterone-sulfate (DS) and testosterone (T) were measured by radioimmunoassay to define the source of androgen excess in hirsute women. Four patients (7%) failed to have adequate adrenal suppression due to failure in medication. Among the 51 patients with adequate adrenal suppression, the source of androgen excess was clearly defined in 48 patients (94%). Seventeen patients (33%) showed ovarian source, 13 patients (26%) had adrenal source, while 18 patients (35%) revealed a mixed adrenal and ovarian source. Normal baselines DS and T levels were noted in 22% of hirsute women and more than half (55%) of them had ovarian androgen excess. Even in 17 patients with normal DS and elevated T, 6 patients (36%) suggested adrenal androgen excess. The source of androgen excess in hirsute women seems evenly distributed among the ovarian, the adrenal, and the mixed group.
D000307:Adrenal Gland Diseases / Q000175:diagnosis; D003687:Dehydroepiandrosterone / Q000031:analogs & derivatives* / Q000097:blood; D019314:Dehydroepiandrosterone Sulfate; D003907:Dexamethasone; D005260:Female; D006628:Hirsutism / Q000097:blood / Q000175:diagnosis*; D006801:Humans; D008599:Menstruation Disturbances / Q000209:etiology; D010049:Ovarian Diseases / Q000175:diagnosis; D013739:Testosterone / Q000097:blood*
D013739:Testosterone; D003687:Dehydroepiandrosterone; D019314:Dehydroepiandrosterone Sulfate; D003907:Dexamethasone